Actif À Court Terme Changement Date
Acadia Pharmaceuticals USD 1.06B 14.31M 2025-12
Agios Pharmaceuticals USD 834.84M 107.21M 2026-03
Akebia Therapeutics USD 252.96M 5.38M 2025-12
Alnylam Pharmaceuticals USD 4.22B 168.65M 2026-03
Amgen USD 31.48B 2.42B 2026-03
Ardelyx USD 381.87M 447K 2026-03
Astellas Pharma JPY 1.42T 19.35B 2026-03
AstraZeneca USD 29.61B 890M 2026-03
Bayer EUR 32.91B 30M 2025-12
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Celltrion KRW 5.54T 291.68B 2025-09
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Deva Holding AS TRY 9.13B 1.61B 2023-09
Dianthus Therapeutics USD 1.12B 710.47M 2026-03
Exelixis USD 1.44B 41.03M 2025-12
Fresenius Medical Care EUR 7.9B 74M 2025-12
GlaxoSmithKline GBP 17.76B 251M 2026-03
Ionis Pharmaceuticals USD 2.94B 52M 2026-03
Ironwood Pharmaceuticals USD 273.84M 82.09M 2025-09
J&J USD 59.17B 3.55B 2026-03
Kangmei Pharma CNY 7.03B 128.34M 2025-09
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Knight Therapeutics CAD 394.84M 5.86M 2025-12
Laboratorios Farma EUR 509.33M 128.63M 2023-12
Lexicon Pharmaceuticals USD 101.9M 20.63M 2025-12
Malin Corporation EUR 62.6M 26.7M 2024-12
Medical Developments International AUD 33.75M 1.79M 2025-12
Moderna USD 5.77B 774M 2026-03
Nektar Therapeutics USD 266.27M 15.09M 2025-12
Neuren Pharmaceuticals AUD 332.23M 11.98M 2025-12
Organigram Holdings CAD 256.54M 28.35M 2025-12
Ovoca Bio EUR 1.56M 3.39M 2025-06
Pharma Mar EUR 273.45M 9.96M 2026-03
Prothena USD 315.19M 24.78M 2025-12
PTC Therapeutics USD 2.27B 266.14M 2025-12
Qiagen NV USD 2B 535.87M 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
Sarepta Therapeutics USD 2.54B 184.37M 2025-12
Sartorius EUR 1.92B 157.2M 2026-03
Sino Biopharmaceutical CNY 33.82B 9.13B 2025-06
Tectonic Therapeutic USD 257.36M 15.88M 2025-12
Tilray USD 729.32M 28.18M 2025-09
Vanda Pharmaceuticals USD 347.26M 20.23M 2025-12
Zealand Pharma A/S 15.67B 950.94M 2025-12
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03